DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹2.00 Cr | - | - | - | ₹0.35 Cr |
What is the latest Total Debt ratio of DIVIS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | ₹0.35 Cr |
How is Total Debt of DIVIS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | -100.00 | |
| Mar2021 | ₹0.35 Cr | - | |
Compare Total Debt of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹177,677.9 Cr | -1.7% | 9.3% | 12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,287.0 Cr | -0.6% | 4% | -6.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,202.0 Cr | 5.2% | 7% | 11.9% | Stock Analytics | |
| CIPLA | ₹122,276.0 Cr | 0.1% | 1.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,024.0 Cr | 0.2% | -2.9% | -4.9% | Stock Analytics | |
| MANKIND PHARMA | ₹92,301.0 Cr | -6.9% | -8.7% | -17.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.7% |
9.3% |
12.9% |
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses